Lymphir Alternatives Compared
Lymphir | Targretin | Clobetasol topical |
|
---|
Lymphir (denileukin diftitox) | Targretin (bexarotene) | Clobetasol topical |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Lymphoma, Cutaneous T-cell Lymphoma. Lymphir may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Cutaneous T-cell Lymphoma. Targretin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Anal Itching, Cutaneous T-cell Lymphoma, Atopic Dermatitis, Dermatitis, Dermatological Disorders, Eczema, Lichen Planopilaris, Lichen Planus, Lichen Sclerosus, Necrobiosis Lipoidica... View more |
Related suggestions Cutaneous T-cell Lymphoma
|
|||||||
More about Lymphir | More about Targretin (bexarotene) | More about Clobetasol topical | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Targretin has an average rating of 9.5 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Clobetasol topical has an average rating of 8.3 out of 10 from a total of 160 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 13% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Lymphir side effects in more detail. |
See also: Targretin side effects in more detail. |
See also: clobetasol topical side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
Lower cost generic |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Targretin prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | ||||||||||
N/A |
|
|
||||||||
Brand Names | ||||||||||
N/A |
N/A |
Clobevate, Clobex, Clodan, Cormax, Cormax Scalp, Dermovate, Embeline, Embeline E, Impeklo, Impoyz, Olux, Olux-E, Temovate, Temovate Emollient, Tovet View more | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
1.3 hours |
7 hours |
N/A |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 167 drugs are known to interact with Lymphir:
|
A total of 623 drugs are known to interact with Targretin:
|
A total of 48 drugs are known to interact with clobetasol topical:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
December 29, 1999 |
December 27, 1985 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
N/A |
||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.